October 2023

VANCOUVER, CANADA, and REHOVOT, ISRAEL, October 30, 2023 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) is pleased to announce that it has closed the first tranche of its non-brokered private placement of convertible notes (the “Notes”) previously announced on October 19 and October 20, 2023. The Company has issued Notes in the […]

Vancouver, British Columbia and Rehovot, Israel – October 10th, 2023, BioHarvest Sciences Inc, (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) (“BioHarvest” or “the Company”) announces that VINIA®, its flagship nutraceutical product derived from red grape cells, has received its Canadian product license from Health Canada’s Natural and Non-Prescription Health Products Directorate. This Product License authorizes BioHarvest